Saudi Arabia Cancer Diagnostics Market Size & Outlook
Saudi Arabia cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Saudi Arabia cancer diagnostics market highlights
- The Saudi Arabia cancer diagnostics market generated a revenue of USD 938.4 million in 2023 and is expected to reach USD 1,394.7 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 938.4 million |
| Market revenue in 2030 | USD 1,394.7 million |
| Growth rate | 5.8% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.9% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 609.1 million by 2030.
Consumables was the largest segment with a revenue share of 60.02% in 2023. Horizon Databook has segmented the Saudi Arabia cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the country’s market can primarily be attributed to the increasing involvement of the government and rising awareness about the benefits of noninvasive diagnostic procedures. In addition, rapid advancements in NGS and PCR technologies have improved the accuracy of diagnostic techniques over the years.
Moreover, local as well as international market players are focusing on expanding their networks in Saudi Arabia, as awareness and adoption of advanced technologies are increasing in the country.
For instance, in July 2021, OncoDNA, a leader in liquid biopsy, Bayer Saudi Arabia, & Tamkin Al-Seha Medical announced a partnership to broaden access to biomarker testing and identify patients eligible for treatment with TRK inhibitors in Saudi Arabia. This partnership would improve treatment rates in the coming years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia cancer diagnostics market size, by product, 2018-2030 (US$M)
Saudi Arabia Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
